about
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)How I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Primary immunodeficiencies associated with eosinophiliaMechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesCauses and consequences of the autoimmune lymphoproliferative syndromeCo-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndromeNew advances in the diagnosis and treatment of autoimmune lymphoproliferative syndromeAutoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.FOXP3 acts as a rheostat of the immune response.Exposure to inorganic mercury in vivo attenuates extrinsic apoptotic signaling in Staphylococcal aureus enterotoxin B stimulated T-cellsCaspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder.Genetic defects of apoptosis and primary immunodeficiency.cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutationsSmad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders.Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).Bottom-up synthetic biology: modular design for making artificial platelets.A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.In Vitro Evaluation of the Apoptosis Function in Human Activated T Cells
P2860
Q24623371-558C0D67-E31C-4272-A3B8-D584C50EBE6BQ24633207-3C506E17-AD75-4B46-8D4F-E9BE1D5F1E40Q24643047-B2511BFA-02B9-4EDE-95FA-7389C1162ED2Q26746046-91A7649F-D61E-4F59-9CDA-C7576318CB52Q28066193-05D6DAAA-4D10-4FBB-B6F5-1E9F68DC0876Q28300792-E921FC71-BC01-40E5-BC68-9BF146812EEDQ30838565-135A68A3-1769-43A3-A9AC-08973C29D127Q34239719-A1ECF0C8-6132-414D-9C39-21F39C384A58Q34513178-222492BC-82E9-4919-84A0-E2C9DC3315A4Q36015032-BE74F8B3-5679-498A-8822-766436348D53Q36375052-7A758D37-E3B2-4D6C-A6A3-26B06264645DQ36403055-555233C0-6557-4DB3-86F7-619BB0D69F26Q37142878-6AF14940-0614-4D43-BE0B-51001394B922Q37272180-A76588A6-07DD-4C8D-8B91-3AF11DD7E6DDQ37670054-9440AC4C-8D88-4801-8705-A8EC75B37F97Q37696996-517F96A0-DC8D-4300-9B37-F0470F61CA69Q38558955-0152BBA1-42F2-47D6-BDF5-CCD2B079512CQ38845230-F79FEF3E-9EF1-4F2B-9117-A0BAC012A74EQ47392447-53B5889A-9BC6-4766-8DEF-06B435927912Q48283620-4C8E8A99-5AEA-42FE-ACEA-BFF824FB26B8Q51936361-38227348-0873-4638-8FCA-A45052785154Q57078451-9B4D2761-4284-43F9-BE63-4D21A69F376F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Autoimmune lymphoproliferative syndrome
@ast
Autoimmune lymphoproliferative syndrome
@en
Autoimmune lymphoproliferative syndrome
@nl
type
label
Autoimmune lymphoproliferative syndrome
@ast
Autoimmune lymphoproliferative syndrome
@en
Autoimmune lymphoproliferative syndrome
@nl
prefLabel
Autoimmune lymphoproliferative syndrome
@ast
Autoimmune lymphoproliferative syndrome
@en
Autoimmune lymphoproliferative syndrome
@nl
P2093
P3181
P1476
Autoimmune lymphoproliferative syndrome
@en
P2093
Janet K Dale
Michael C Sneller
Stephen E Straus
P304
P3181
P356
10.1097/00002281-200307000-00008
P407
P577
2003-07-01T00:00:00Z